Trump admin unveils health pricing disclosure rules — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Trump administration released new regulations Monday requiring health insurance companies to publish cleaned-up spreadsheets of prices paid to hospitals and doctors, stripping out meaningless data that previously clogged the files.
- Mehmet Oz, head of Medicare and Medicaid, said at a Monday event that officials will begin developing the prescription drug price disclosure system next month and target a "hopeful" final drug pricing plan by next May.
- The administration said it will enforce prescription drug price disclosure requirements by the end of 2027.
- The Trump administration's last-year punt on finalizing drug price disclosure rules was a victory for drug companies and pharmacy benefit managers that have fiercely guarded their prices, the source notes.
Why it matters: The administration released cleaned-up insurance pricing disclosure rules Monday, but drug price transparency enforcement won't arrive until end of 2027 — giving drug companies and pharmacy benefit managers, who blocked last year's rules, continued runway to guard their negotiated pricing.
Ask SkimNews
